HEPATITIS D
Clinical trials for HEPATITIS D explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS D trials appear
Sign up with your email to follow new studies for HEPATITIS D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to tame rare liver virus
Disease control OngoingThis study tests a new drug called hepalatide (L47) in 90 adults with chronic hepatitis D, a serious liver infection. Participants receive either a low or high dose of the drug daily for 48 weeks, or wait for treatment. The goal is to see if the drug can lower the virus level and…
Matched conditions: HEPATITIS D
Phase: PHASE2 • Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug may ease liver pressure in hepatitis d patients
Disease control OngoingThis study looks at whether the drug Bulevirtide can reduce high blood pressure in the liver (portal hypertension) in people with hepatitis B and D who also have liver cirrhosis. High liver pressure can lead to serious problems, and this treatment aims to control it by suppressin…
Matched conditions: HEPATITIS D
Sponsor: Hannover Medical School • Aim: Disease control
Last updated May 13, 2026 16:03 UTC